Cited by 476Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesMetabolism, Diabetes, and Cancer

Insulin Activation of Phosphatidylinositol 3-Kinase in the Hypothalamic Arcuate Nucleus

Niswender, Kevin D., Morrison, Christopher D., Clegg, Deborah J., Olson, Ryan, Baskin, Denis G., Myers, Martin G., Seeley, Randy J., Schwartz, Michael W.·2003·Diabetes

Abstract

In peripheral tissues, insulin signaling involves activation of the insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase (PI3K) enzyme system. In the hypothalamus, insulin functions with leptin as an afferent adiposity signal important for the regulation of body fat stores and hepatic glucose metabolism. To test the hypothesis that hypothalamic insulin action involves intracellular PI3K signaling, we used histochemical and biochemical methods to determine the effect of insulin on hypothalamic IRS-PI3K activity. Here, we report that insulin induces tyrosine phosphorylation of the insulin receptor and IRS-1 and -2, increases binding of activated IRS-1 and -2 to the regulatory subunit of PI3K, and activates protein kinase B/Akt, a downstream target of PI3K. Using an immunohistochemical technique to detect PI 3,4,5-triphosphate, the main product of PI3K activity, we further demonstrate that in the arcuate nucleus, insulin-induced PI3K activity occurs preferentially within cells that contain IRS-2. Finally, we show that the food intake- lowering effects of insulin are reversed by intracerebroventricular infusion of either of two PI3K inhibitors at doses that have no independent feeding effects. These findings support the hypothesis that the IRS-PI3K pathway is a mediator of insulin action in the arcuate nucleus and, combined with recent evidence that leptin activates PI3K signaling in the hypothalamus, provide a plausible mechanism for neuronal cross-talk between insulin and leptin signaling.

Integrity signals

Registry

Crossref · 10.2337/diabetes.52.2.227

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Like insulin, leptin activates the IRS-PI3K pathway in the hypothalamus, and pharmacological inhibition of PI3K in the brain blocks leptin's ability to reduce food intake.

    “like insulin, leptin activates the IRS-PI3K pathway in the hypothalamus, and pharmacological inhibition of PI3K activity in the brain blocks the ability of leptin to reduce food intake (129, 130).”
  • PI3K is required for insulin to inhibit food intake.

    “PI3K is also required for the ability of insulin to inhibit food intake (129).”
  • Insulin activates the IRS-PI3K pathway in hypothalamic neurons.

    “Like leptin, insulin also activates the IRS-PI3K pathway in hypothalamic neurons”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Niswender, K. D., Morrison, C. D., Clegg, D. J., Olson, R., Baskin, D. G., Myers, M. G., Seeley, R. J., & Schwartz, M. W.
Affiliations
  • University of Washington (US)
  • University of Cincinnati (US)
  • Joslin Diabetes Center (US)
Venue
Diabetes
Published
2003-02-01
Volume
52
Issue
2
Pages
227-231
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2102743478
Cited by
476
References
28
Citations by year
2026: 6 · 2025: 10 · 2024: 2 · 2023: 7 · 2022: 2 · 2021: 22 · 2020: 15 · 2019: 22 · 2018: 13 · 2017: 19 · 2016: 24 · 2015: 14 · 2014: 23 · 2013: 22 · 2012: 32
FWCI
13.81
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (2r01dk012829-36)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK56731, DK 12829, T32-DK-07247, R01DK052989, DK-52989, R01DK054890, DK-17047, DK-54890, P30DK017047, T32DK007247)
  • National Institute of Neurological Disorders and Stroke (NS-32273)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
insulin signaling, phosphatidylinositol 3-kinase, IRS-1, insulin receptor substrate 2, hypothalamic arcuate nucleus, Akt/protein kinase B, insulin receptor tyrosine phosphorylation, food intake regulation, leptin signaling, hepatic glucose metabolism
MeSH terms
Animals, Anorexia, Arcuate Nucleus of Hypothalamus, Disease Models, Animal, Enzyme Activation, Insulin, Rats, Wistar, Phosphatidylinositol 4,5-Diphosphate, Phosphatidylinositol 3-Kinases, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review